Spyre Therapeutics (SYRE) Asset Utilization Ratio (2016 - 2024)
Spyre Therapeutics posted quarterly Asset Utilization Ratio of 0.0 for Q1 2024, down 91.2% year-on-year from 0.02 in Q2 2023, and down 48.59% on a QoQ basis from 0.0 in Q4 2023.
Spyre Therapeutics (SYRE) has 8 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2024.
- For the quarter ending Q1 2024, Asset Utilization Ratio fell 91.2% year-over-year to 0.0; the trailing twelve-month figure through Mar 2024 stood at 0.0 (down 91.2% YoY), and the FY2023 full-year result was 0.0, down 83.32% from the prior year.
- Asset Utilization Ratio for Q1 2024 stood at 0.0, down from 0.0 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.3 in Q1 2022 and bottomed at 0.0 in Q1 2024.
- The 4-year median for Asset Utilization Ratio is 0.04 (2022), against an average of 0.09.
- The widest annual swing landed in 2022, when Asset Utilization Ratio jumped 140.34%; it then sank 95.53% in 2023.
- A 4-year view of Asset Utilization Ratio shows it stood at 0.23 in 2021, then slumped by 87.63% to 0.03 in 2022, then tumbled by 88.73% to 0.0 in 2023, then plunged by 48.59% to 0.0 in 2024.
- The last three Asset Utilization Ratio figures came in at 0.0 (Q1 2024), 0.0 (Q4 2023), and 0.0 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.19 |
| Mar 31, 2022 | 0.30 |
| Dec 31, 2021 | 0.23 |
| Sep 30, 2021 | 0.17 |
| Jun 30, 2021 | 0.08 |
| Mar 31, 2019 | 0.02 |
| Dec 31, 2018 | 0.05 |
| Sep 30, 2018 | 0.07 |
| Jun 30, 2018 | 0.10 |
| Mar 31, 2018 | 0.11 |
| Dec 31, 2017 | 0.09 |
| Sep 30, 2017 | 0.08 |
| Jun 30, 2017 | 0.08 |
| Mar 31, 2017 | 0.07 |
| Dec 31, 2016 | 0.07 |
| Sep 30, 2016 | 0.07 |
| Jun 30, 2016 | 0.09 |
| Mar 31, 2016 | 0.19 |